Calcium Chloride

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Calcium Chloride
Generic name
CALCIUM CHLORIDE
Manufacturer
REMEDYREPACK INC.
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
801f110c-7800-4689-a37a-f31d99c0f930
SPL ID
5a200b6c-c25e-c110-e063-6394a90a2c3b
Version
4
Effective date
2026-08-28
Source export date
2026-10-30
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-30/e37bebe0ee356110e46fe9b102632217cd5fd64caa93a64cf6ef0d92a0bfdb4c/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run
20261102T182004Z
Imported at
2026-11-02 18:51:56
Harmonized routes table
Harmonized routes
INTRAVENOUS, INTRAVENTRICULAR

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS Rapid injection may cause the patient to complain of tingling sensations, a calcium taste, a sense of oppression or “heat wave”. Injections of calcium chloride are accompanied by peripheral vasodilatation as well as a local “burning” sensation and there may be a moderate fall in blood pressure. Should perivascular infiltration occur, I.V. administration at that site should be discontinued at once. Local infiltration of the affected area with 1% procaine hydrochloride, to which hyaluronidase may be added, will often reduce venospasm and dilute the calcium remaining in the tissues locally. Local application of heat may also be helpful.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.